Etoricoxib 90 Tablet

About Etoricoxib 90 Tablet

Etoricoxib 90 is a tablet from Central Pharmaceutical Ltd., with the generic name Etoricoxib. It is also for short-term treatment of moderate pain after dental surgery.

There are 90 brands of Etoricoxib listed in Bangladesh. The lowest listed price is Retoz 90 mg Tablet at ৳ 1 per unit.

What is Etoricoxib 90 Tablet?

Etoricoxib 90 90 mg is a tablet product of Central Pharmaceutical Ltd. that contains Etoricoxib. It is used for symptomatic relief in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Doctors prescribe Etoricoxib 90 for specific conditions such as acute gouty arthritis and other inflammatory joint problems. Whether it suits you is a decision for your doctor.

Uses of Etoricoxib 90

It is also for short-term treatment of moderate pain after dental surgery. Etoricoxib 90 90 mg tablet is used for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is an NSAID, so it eases pain and inflammation rather than treating the underlying cause. Ask your doctor what your course is for and how long it should last.

How to use Etoricoxib 90

If you have trouble swallowing tablets, ask your pharmacist for advice. Etoricoxib 90 is taken by mouth. Swallow the tablet with water. Take Etoricoxib 90 90 mg tablet exactly as your doctor prescribes. The dose and length of treatment depend on your condition. The doctor will decide how long you need to take it.

Side effects of Etoricoxib 90

Like other medicines, Etoricoxib 90 can cause side effects. Confusion and hallucinations are very rare. Contact your doctor if you notice anything unusual after taking it. Tell your doctor about any side effect that bothers you or does not settle.

Safety and precautions

It should not be used with active stomach ulcer or bleeding, inflammatory bowel disease, severe liver or kidney problems, certain heart failure, or during pregnancy and breastfeeding. Always inform your doctor about all your medical conditions and medicines before starting this tablet. It is also not for people who have had allergic-type reactions to aspirin or other NSAIDs, or with severe liver or kidney problems, certain heart failure, or inflammatory bowel disease, among other conditions. Tell your doctor about all your health conditions and medicines before starting, and ask your doctor first if you are unsure whether it is right for you.

Frequently asked questions

What is Etoricoxib 90 used for?

It is also for short-term treatment of moderate pain after dental surgery. Etoricoxib 90 90 mg tablet is used for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

How should I take Etoricoxib 90?

If you have trouble swallowing tablets, ask your pharmacist for advice. Etoricoxib 90 is taken by mouth.

What should I watch for while using Etoricoxib 90?

Like other medicines, Etoricoxib 90 can cause side effects. Confusion and hallucinations are very rare.

Can I use Etoricoxib 90 in pregnancy or while breastfeeding?

It should not be used with active stomach ulcer or bleeding, inflammatory bowel disease, severe liver or kidney problems, certain heart failure, or during pregnancy and breastfeeding. Always inform your doctor about all your medical conditions and medicines before starting this tablet.

Also available as

90 mg (Tablet)

Indications

Etoricoxib is indicated for the symptomatic relief of-
  • Osteoarthritis (OA)
  • Rheumatoid arthritis (RA)
  • Ankylosing spondylitis, and
  • The pain and signs of inflammation associated with acute gouty arthritis.
  • For the short-term treatment of moderate pain associated with dental surgery.

Pharmacology

Etoricoxib is a potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor within, and significantly above, the clinical dose range. Two isoforms of cyclooxygenase have been identified: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 is responsible for prostaglandin-mediated normal physiologic functions such as gastric cytoprotection and platelet aggregation. Inhibition of COX-1 by nonselective NSAIDs has been associated with gastric damage and inhibition of platelet aggregation. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Selective inhibition of COX-2 by etoricoxib (within the clinical dose range) decreases these clinical signs and symptoms with decreased potential for Gl toxicity and effects on platelet aggregation. Etoricoxib produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily. Etoricoxib did not inhibit gastric prostaglandin synthesis.

Dosage & Administration

Adult and adolescent over 16 years:
  • Osteoarthritis: The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.
  • Rheumatoid arthritis: The recommended dose is 90 mg once daily.
  • Ankylosing spondylitis: The recommended dose is 90 mg once daily.
  • Acute gouty arthritis: The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.
  • Postoperative dental surgery pain: The recommended dose is 90 mg once daily, limited to a maximum of 3 days.
Some patients may require additional postoperative analgesia. As the cardiovascular risks of Etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis.

Interaction

With medicine:
  • Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Etoricoxib was associated with an increase in prothrombin time.
  • Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.
  • Acetylsalicylic Acid: Etoricoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).
  • Ciclosporin and tacrolimus: Although this interaction has not been studied with Etoricoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.
  • Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels.
With food & others: Take without regards to meals.

Contraindications

  • Hypersensitivity to the active substance or to any of the excipients.
  • Active peptic ulceration or active gastro-intestinai (Gl) bleeding.
  • Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.
  • Pregnancy and lactation.
  • Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).
  • Estimated renal creatinine clearance <30 ml/min.
  • Children and adolescents under 16 years of age.
  • Inflammatory bowel disease.
  • Congestive heart failure (NYHA ll-IV).
  • Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
  • Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease.

Side Effects

Side-effects may include palpitation, fatigue, influenza-like symptoms, ecchymosis; less commonly dry mouth, taste disturbance, mouth ulcer, appetite and weight change, atrial fibrillation, transient ischaemic attack, chest pain, flushing, cough, dyspnoea, epistaxis, anxiety, mental acuity impaired, paraesthesia, electrolyte disturbance, myalgia and arthralgia; very rarely confusion and hallucinations.

Pregnancy & Lactation

The use of Etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. It is not known whether Etoricoxib is excreted in human milk. Etoricoxib is excreted in the milk of lactating rats. Women who use Etoricoxib must not breastfeed.

Precautions & Warnings

  • Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.
  • Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Etoricoxib after careful consideration.
  • Administration of Etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.
  • Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.
  • Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Etoricoxib should be discontinued.
  • Etoricoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.
  • Etoricoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering Etoricoxib with warfarin or other oral anticoagulants.

Overdose Effects

Administration of single doses of Etoricoxib up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. In the event of overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the Gl tract, employ clinical monitoring, and institute supportive therapy, if required.

Storage Conditions

Store at a temperature of below 30°C, protect from light & moisture. Keep out of reach of children.

Alternative brands of Etoricoxib

Other brands with the same generic name, cheapest first.

Algirex Tablet

60 mg

Etoricoxib

Ibn Sina Pharmaceuticals Ltd.

৳ 6.86 ৳ 7.00 2% off per unit

Artorix Tablet

60 mg

Etoricoxib

Asiatic Laboratories Ltd.

৳ 6.86 ৳ 7.00 2% off per unit

Eto Tablet

60 mg

Etoricoxib

Delta Pharma Limited

৳ 6.86 ৳ 7.00 2% off per unit

Etoriflex Tablet

60 mg

Etoricoxib

Somatec Pharmaceuticals Ltd.

৳ 6.86 ৳ 7.00 2% off per unit

Oricox Tablet

60 mg

Etoricoxib

Incepta Pharmaceuticals Ltd.

৳ 6.86 ৳ 7.00 2% off per unit

Eroflam Tablet

60 mg

Etoricoxib

Orion Pharma Ltd.

৳ 6.88 ৳ 7.02 2% off per unit

Rito Tablet

60 mg

Etoricoxib

Opsonin Pharma Limited

৳ 6.89 ৳ 7.03 2% off per unit

Setorib Tablet

60 mg

Etoricoxib

The ACME Laboratories Ltd.

৳ 6.9 ৳ 7.04 2% off per unit

Coxia Tablet

60 mg

Etoricoxib

Advanced Chemical Industries PLC

৳ 6.91 ৳ 7.05 2% off per unit

Aroxia Tablet

60 mg

Etoricoxib

Ad-din Pharmaceuticals Ltd.

৳ 7.84 ৳ 8.00 2% off per unit

See all 90 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.